Ferret-Sena, V., Silva, A. M. e., Sena, A., Cavaleiro, I., Vale, J., Derudas, B., . . . Staels, B. (2017). Natalizumab treatment modulates Peroxisome Proliferator-Activated Receptors expression in women with multiple sclerosis.
Chicago Style (17th ed.) CitationFerret-Sena, Véronique, Alexandra Maia e. Silva, Armando Sena, Inês Cavaleiro, José Vale, Bruno Derudas, Giulia Chinetti-Gbaguidi, and Bart Staels. Natalizumab Treatment Modulates Peroxisome Proliferator-Activated Receptors Expression in Women with Multiple Sclerosis. 2017.
MLA (8th ed.) CitationFerret-Sena, Véronique, et al. Natalizumab Treatment Modulates Peroxisome Proliferator-Activated Receptors Expression in Women with Multiple Sclerosis. 2017.
Warning: These citations may not always be 100% accurate.